Cessatech A/S (NGM:CESSA)

Market Cap	294.87M
Revenue (ttm)	3.82M
Net Income (ttm)	-22.54M
Shares Out	17.43M
EPS (ttm)	-1.31
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,379
Average Volume	28,174
Open	8.40
Previous Close	8.46
Day's Range	7.70 - 8.40
52-Week Range	n/a
Beta	0.38
RSI	66.86
Earnings Date	Apr 24, 2025

About Cessatech

Cessatech A/S, a pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark. The company’s lead product is CT001, an analgesic nasal spray for the treatment of acute and planned painful procedures in children. It also develops CT002, a nasal spray for sedative procedures for children from 0-17 years of age; and CT003, a local anesthetic gel. The company has a collaboration and license agreement with Ventis Pharma Corporation to develop and formulate pain management therapies. Cessatech A/S...

• Industry: Pharmaceutical Preparations
• Founded: 2020
• Employees: 4
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: CESSA

Financial Performance

Financial numbers in DKK